BOS puts the recent price increase down to the release of a research report by Southern Cross Equities which apparently was very bullish on Biosignal's prospects and provided a solid valuation.
I am trying to track down a copy (its not going to be posted on their website) but if anyone else can get hold of a copy and post the details, it would be much appreciated.
Cheers
